Oncology Drugs Market 2021 Analysis by Leading Key Players – Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the Oncology Drugs market segments which include products, applications, and competitor analysis. The report also includes a detailed study of key companies to provide insights into business strategies, company summary, financial summary, business strategy and planning, SWOT analysis and current developments adopted by various players in order to sustain competition in this highly competitive environment.

 (Special Offer: Available 25% Flat Discount For Limited Time Only)

Get a Free Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/06293019657/global-oncology-drugs-market-size-status-and-forecast-2021-2027/inquiry?mode=700

Top Companies in the Global Oncology Drugs Market: Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer, Amgen, Eli Lilly, AbbVie, Takeda, Astellas, Ipsen, Sanofi, Bayer, Biogen Idec, Teva, Otsuka, Eisai, Merck KGaA, Gilead Sciences 

The global oncology drugs market size was valued at USD 141.33 billion in 2019 and is projected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the forecast period.

Market Overview:

The top opportunities in the oncology drugs market segmented by type will arise in the blood cancer segment, which will gain $16.2 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by drug class type will arise in the targeted therapy segment, which will gain $44.0 billion of global annual sales by 2025.The top opportunities in the oncology drugs market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $48.2 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by drug classification will arise in the branded drugs segment, which will gain $76.5 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by route of administration will arise in the oral segment, which will gain $48.7 billion of global annual sales by 2025. The oncology drugs market size will gain the most in the USA at $36.5 billion.

Industry News:

June 2021 – Bayer AG announced that they entered into an agreement to acquire of Noria Therapeutics Inc. and PSMA Therapeutics Inc. Through this agreement Bayer will have exclusive rights of the company’s investigational compound. This acquisition will help Bayer to expand their oncology portfolio.

April 2021– Sanofi announced that they have acquired Tidal Therapeutics, a pre-clinical biotech company responsible for the development of a mRNA based research platform. This acquisition will help Sanofi leverage this new technology platform to expand their research capabilities in the field of oncology, immunology and other disease areas.

Market Segmentation by Types:

Chemotherapy

Targeted Therapy

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Others

Market Segmentation by Applications:

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory or Lung Cancer

Others

The study objectives of this report are:

-An overview of the global market for Global Oncology Drugs Market and related technologies.
-Analyses of global market trends, with data from 2020, and projections of compound annual growth rates (CAGRs) through 2027.
-Identifications of new market opportunities and targeted promotional plans for Global Oncology Drugs Market.

-Discussion of research and development, and the demand for new products and new applications.

Regional Analysis For Oncology Drugs Market:

For extensive understanding of market dynamics, the global Oncology Drugs market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India and others. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Read the full report:

https://www.marketinsightsreports.com/reports/06293019657/global-oncology-drugs-market-size-status-and-forecast-2021-2027?mode=700

Significant Features that are under Offering and Key Highlights of the Reports:

– Detailed overview of Oncology Drugs Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc
– Historical, current and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of Oncology Drugs Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.

The research includes historic data from 2016 to 2021 and forecasts until 2027 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Free customization of the report: This report can be further customized according to the client’s specific requirements. No additional charges will be added for limited additional research

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.